dc.creatorQuitete V.H.A.C.
dc.creatorFavaro W.J.
dc.date2009
dc.date2015-06-26T13:37:17Z
dc.date2015-11-26T15:38:00Z
dc.date2015-06-26T13:37:17Z
dc.date2015-11-26T15:38:00Z
dc.date.accessioned2018-03-28T22:46:27Z
dc.date.available2018-03-28T22:46:27Z
dc.identifier
dc.identifierInternational Journal Of Experimental Pathology. , v. 90, n. 2, p. 156 - 165, 2009.
dc.identifier9599673
dc.identifier10.1111/j.1365-2613.2008.00624.x
dc.identifierhttp://www.scopus.com/inward/record.url?eid=2-s2.0-62749135961&partnerID=40&md5=9e4b1ba10fae822904accfcda0d46178
dc.identifierhttp://www.repositorio.unicamp.br/handle/REPOSIP/92725
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/92725
dc.identifier2-s2.0-62749135961
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1263786
dc.descriptionDystroglycan (DG) is an adhesion protein which plays a crucial role in the maintenance of tissue integrity. Diabetes has been pointed out as a disease which causes harmful effects on prostate function. Therefore, the main objective of this work was to verify DG distribution and structure features in diabetic mice with and without glycaemic control and to relate these parameters to prostate pathogenesis. Thirty mice (Nod and BALB/c) were divided into three groups after 20 days of diabetic state: the control group received a 5 ml/kg dose of physiological saline daily for 20 days; the diabetic group had the same treatment as the control group; the diabetic-insulin group received 4-5 IU doses of Neutral Protamine Hagedorn (NPH) insulin daily for 20 days. After 20 days of treatment, all animals were killed and samples from the ventral prostate were processed for immunological and light microscopy analyses. The results showed diminished β- and α-DG receptors in the diabetic group. However, there was a recovery of both β-and α-DG receptor immunolocalization after insulin administration. Epithelial and stromal morphological changes were verified in the diabetic group, which also presented recovery after insulin treatment. Thus, it could be concluded that diabetes disturbed prostate structure integrity and altered the occurrence of α and β-DG receptors, indicating decreased cell-matrix extracellular and cell-basal membrane attachment. However, insulin treatment could partially restore glandular homeostasis. The decrease in epithelial-stromal interaction certainly predisposes this gland in diabetic mice to be a prostate disease target. © 2009 Blackwell Publishing Ltd.
dc.description90
dc.description2
dc.description156
dc.description165
dc.descriptionAder, M., Richey, J.M., Bergman, R.N., Evidence for direct action of alloxan to induce insulin resistance at the cellular level (1998) Diabetologia, 41, pp. 1327-1336
dc.descriptionAnderson, L.C., Effects of alloxan diabetes and insulin in vivo on rat parotid gland (1983) Am. J. Physiol., 245, pp. 431-437
dc.descriptionAumüller, G., Ader, G., Experimental studies of apocrine secretion in the dorsal prostate ephitelium of the rat (1979) Cell Tissue Res., 198, pp. 145-158
dc.descriptionAumüller, G., Seitz, J., Protein secretion and secretory processes in male accessory sex gland (1990) Int. Rev. Citol., 121, pp. 127-231
dc.descriptionBallester, J., Munoz, M.C., Dominguez, J., Rigau, T., Guinovart, J.J., Rodriguez-Gil, J.E., Insulin-dependent diabetes affects testicular function by FSH- and LH-linked mechanisms (2004) J. Androl., 25, pp. 706-719
dc.descriptionBasaria, S., Muller, D.C., Carducci, M.A., Egan, J., Dobs, A.S., Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy (2006) Cancer, 106, pp. 581-588
dc.descriptionBehmer, O.A., Tolosa, E.M.C., Freitas-Neto, A.G., (1976) Manual Para Histologia Normal e Patológica., , São Paulo: Edart-Edusp, P. 225
dc.descriptionBrennan, P., Jing, J., Ethunandan, M., Gorecki, D., Dystroglycan complex in cancer (2004) Eur. J. Surg. Oncol., 30, pp. 589-592
dc.descriptionBuck, A.C., Reed, P.I., Siddiq, Y.K., Chisholm, G.P., Russel, E.T., Bladder dysfunction and neuropathy in diabetes (1976) Diabetologia, 12, p. 251
dc.descriptionCagnon, V.H.A., Camargo, A.M., Rosa, R.M., Fabiani, C.R., Padovani, C.R., Martinez, F.E., Ultra structure study of the ventral lobe of the prostate of mice with streptozotocin induced diabetes (C57bl/6j) (2000) Tissue Cell, 32, pp. 275-283
dc.descriptionCaldeira, E.J., Cagnon, V.H.A., IGF-I and INS receptor expression in the salivary glands of diabetic Nod mice submitted to long-term insulin treatment (2007) Cell Biol. Int., 32, pp. 16-21
dc.descriptionCarvalho, C.A.F., Camargo, A.M., Cagnon, V.H.A., Padovani, C.R., Effects of experimental diabetes on the structure and ultrastructure of the coagulating gland of C57BL/6j and NOD mice (2003) Anat. Rec., 270, pp. 129-136
dc.descriptionCiardullo, A.V., Daghio, M.M., Brunnetti, M., Audit of shared-care program for persons with diabetes: Baselina na 3 annual follow-ups (2004) Acta Diabetol., 41, pp. 9-13
dc.descriptionColombel, M.C., Buttyan, R., Hormonal control of apoptosis: The rat prostate gland prostate as a model system (1995) Methods Cell Biol., 46, pp. 369-385
dc.descriptionConget, I., Diagnosis, classification and pathogenesis of diabetes mellitus (2002) Rev. Esp. Cardiol., 55, pp. 528-538
dc.descriptionCornell, R.J., Rowley, D., Wheller, T., Ali, N., Ayala, G., Neuroepithelial interactions in prostate cancer are enhanced in the presence of prostatic stroma (2003) Urology, 61, pp. 870-875
dc.descriptionCostello, C.L., Franklin, B.R., Effects of prolactin on the prostate (1994) Prostate, 24, pp. 162-166
dc.descriptionCunha, G.R., Matrisian, L.M., It's not my fault, blame it on my microenvironment (2002) Differentiation, 70, pp. 469-472
dc.descriptionCunha, G.R., Risbridger, G., Wang, H., Young, P., Evidence that epithelial mesenchymal estrogen receptor-α mediates effects of estrogen on prostatic epithelium (2001) Dev. Biol., 229, pp. 432-442
dc.descriptionCunha, G.R., Hayward, S.W., Wang, Y.Z., Role of stroma in carcinogenesis of the prostate (2002) Differentiation, 70, pp. 473-485
dc.descriptionCunha, G.R., Hayward, S.W., Wang, Y.Z., Ricke, W.A., Role of the stromal microenvironment in carcinogenesis of the prostate (2003) Int. J. Cancer, 107, pp. 1-10
dc.descriptionDaubrese, J.C., Meunier, J., Wilmotte, A.S., Luyckx, A.S., Lefebvre, P.J., Pituitary-testicular axisin diabetic men with and without impotence sexual (1978) Diabete Metab., 4, pp. 233-237
dc.descriptionEkman, P., The prostate as an endocrine organ: Androgens and estrogens (2000) Prostate, 10, pp. 14-18
dc.descriptionEllemberg, M., Sexual function in diabetic patients (1980) Ann. Intern. Med., 92, pp. 331-333
dc.descriptionFrenkel, G.P., Homonnal, Z.P., Drasmin, N., Sofer, A., Kaplan, R., Kraicer, P.F., Fertility of the streptozotocin-diabetic male rat (1978) Andrologia, 10, pp. 127-136
dc.descriptionHammarsten, J., Hogstedt, B., Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia (2002) Eur. Urol., 39, pp. 151-158
dc.descriptionHenry, M.D., Campbell, K.P., A role for dystroglycan in basement membrane assembly (1998) Cell, 95, pp. 859-870
dc.descriptionHenry, M.D., Cohen, M.B., Campbell, K.P., Reduced expression of dystroglycan in breast an prostate cancer (2001) Hum. Pathol., 32, pp. 791-795
dc.descriptionHo, S.M., Prostatic androgen receptor and plasma testosterone levels in streptozotocin-induced diabetic rats (1991) J. Steroid Biochem. Mol. Biol., 38, pp. 67-72
dc.descriptionHood, J.D., Cheresh, D.A., Role of integrins in cell invasion and migration (2002) Nat. Rev. Cancer, 2, pp. 91-100
dc.descriptionHu, Y., Nakagawa, Y., Purushotham, K.R., Humphreys-Beher, M.G., Functional changes in salivary glands of autoimmune disease-prone NOD mice (1992) Am. J. Physiol., 263, pp. 607-614
dc.descriptionHumprhreys-Beher, M.G., Yamachika, S., Yamamoto, H., Salivary gland changes in the NOD mouse model for Sjögren's syndrome: Is there a non-immune genetic trigger? (1998) Eur. J. Morphol., 36, pp. 247-251
dc.descriptionIbraghimov-Beskrovnaya, O., Ervasti, J.M., Leveille, C.J., Slaughter, C.A., Sernett, S.W., Campbell, K.P., Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix (1992) Nature, 355, pp. 696-702
dc.descriptionIlic, M., Vlajinac, H., Marinkovic, J., Case-control study of risk factors for prostate cancer (1996) Br. J. Cancer, 74, pp. 1682-1686
dc.descriptionJackson, F.L., Hutson, J.C., Altered responses to androgens in diabetic male rats (1984) Diabetes, 33, p. 819
dc.descriptionJesik, C.J., Holland, J.M., Lee, C., An anatomic and histologic study of the rat prostate (1982) Prostate, 3, pp. 81-97
dc.descriptionKasper, J.S., Liu, Y., Pollak, M.N., Rifai, N., Giovannucci, E., Hormonal profile of diabetic men and the potential link to prostate cancer (2008) Cancer Causes Control., 19, pp. 703-710
dc.descriptionKnox, J.D., Cress, A.E., Clark, V., Differential expression of extracellular matrix molecules and the alpha 6-integrins in the normal and neoplastic prostate (1994) Am. J. Pathol., 145, pp. 167-174
dc.descriptionKreis, T., Vale, R., (1999) Guidebook to the Extracellular Matrix, Anchor, and Adhesion Proteins., , New York, NY: Oxford University Press
dc.descriptionLeav, I., Lau, K.M., Adams, J.A., Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma (2001) Am. J. Pathol., 159, pp. 79-92
dc.descriptionLin, C.Q., Bissel, M.J., Multi-faceted regulation of cell differentiation by extracellular matrix (1993) FASEB, 7, pp. 737-743
dc.descriptionLosasso, C., Di Tommaso, F., Sgambato, A., Anomalous dystroglycan in carcinoma cell lines (2000) FEBS Lett., 484, pp. 194-198
dc.descriptionLyons, A.J., Jones, J., Cell adhesion molecules, the extracellular matrix and oral squamous carcinoma (2007) Int. J. Oral Maxillofac. Surg., 36, pp. 671-679
dc.descriptionMakino, S., Kunimoto, K., Muraoka, Y., Mizushima, Y., Katagiri, K., Tochino, Y., Breeding of a non-obese, diabetic strain of mice (1980) Exp. Anim., 29, pp. 1-13
dc.descriptionMarker, P.C., Donjacour, A.A., Dahiya, R., Cunha, G.R., Hormonal cellular and molecular control of prostatic development (2003) Dev. Biol., 253, pp. 165-174
dc.descriptionMarkopoulos, A.K., Poulopoulos, A.K., Kavavis, I., Papanayotou, P., Immunohistochemical detection on insulin-like growth factor i in the labial salivary glands of patients with Sjogren's syndrome (2000) Oral Dis., 6, pp. 31-34
dc.descriptionMartin, R.M., Silva, A., Lew, A.M., The Igh-1 sequence of the non-obese diabetic (NOD) mouse assigns it to the IgG2c isotype (1997) Immunogenetics, 46, pp. 167-168
dc.descriptionMcCulloch, D.K., Young, R.J., Prescott, R.J., Campbell, I.W., Clarke, B.F., The natural history of impotence in diabetic men (1984) Diabetologia, 26, pp. 437-440
dc.descriptionMokdad, A.H., The continuing epidemics of obesity and diabetes in the United States (2001) JAMA, 286, p. 1195
dc.descriptionOhta, T., Matsui, K., Miyajima, K., Effect of insulin therapy on renal changes in spontaneously diabetic Torii rats (2007) Exp. Anim., 56, pp. 355-362
dc.descriptionOksanen, A., Testicular lesion of streptozotocin diabetic rats (1975) Horm. Res., 6, pp. 138-144
dc.descriptionPierce, B.L., Plymate, S., Ostrander, E.A., Stanford, J.L., Diabetes mellitus and prostate cancer risk (2008) Prostate, 68, pp. 1126-1132
dc.descriptionRaz, A., Dystroglycan: To adhere or not adhere during cancer progression (2004) Cancer Biol. Ther., 3, pp. 967-975
dc.descriptionRibeiro, D.L., Caldeira, E.J., Candido, E.M., Manzato, A.J., Taboga, S.R., Cagnon, V.H., Prostatic stromal microenvironment and experimental diabetes (2006) Eur. J. Histochem., 50, pp. 51-60
dc.descriptionSaito, M., Nishi, K., Foster-Junior, H.E., Weiss, R.M., Latifpour, J., Effect of experimental diabetes on rat prostate endothelin receptors (1996) Eur. J. Pharm., 310, pp. 197-200
dc.descriptionSetchell, B.P., Brooks, P.E., Anatomy, vasculature. Innervation, and fluids of the male reproductive tract (1988) The Physiology of Reproduction, pp. 753-836. , In: pp. eds. E. Knobil, J. Neill. New York, NY: Raven Press
dc.descriptionSgambato, A., Brancaccio, A., The dystroglycan complex: From biology to cancer (2005) J. Cell. Physiol., 205, pp. 163-169
dc.descriptionSgambato, A., Migaldi, M., Montanari, M., Dystroglycan expression is frequently reduced in human breast and colon cancers and is associated with tumor progression (2003) Am. J. Pathol., 162, pp. 849-860
dc.descriptionSgambato, A., Camerini, A., Amoroso, D., Expression of dystroglycan correlates with tumor grade and predicts survival in renal cell carcinoma (2007) Cancer Biol. Ther., 6, pp. 1840-1846
dc.descriptionShirai, H., Sato, T., Hara, T., Minagi, S., The effect of diabetes mellitus on histopathological changes in the tissues under denture base and without mechanical pressure (1998) J. Oral Rehabil., 5, pp. 715-720
dc.descriptionSoudamani, S., Yuvaraj, S., Malini, T., Balasubramanian, K., Experimental diabetes has adverse effects on the differentiation of ventral prostate during sexual maturation of rats (2005) Anat. Rec., 287, pp. 1281-1289
dc.descriptionStefan, S.F., Definition and classification of diabetes including maturity-onset diabetes of the young (1996) Diabetes Mellitus: A Fundamental and Clinical, pp. 251-295. , In: pp. ed. Stefan, S.F. W.B. Saunders: Philidelphia
dc.descriptionSufrin, G., Scott, W.W., Effect of drug-induced diabetes on response accessory sex organs of castrate rats to testosterone proprionate (1972) Urol. Surg., 23, pp. 534-535
dc.descriptionSugimura, Y., Cunha, G.R., Donjacour, A.A., Morphological and histological study of castration-induced degeneration and androgen-induced regeneration in the mouse prostate (1986) Biol. Reprod., 34, pp. 973-983
dc.descriptionSugita, S., Saito, F., Tang, J., Satz, J., Campbell, K., Südhof, T.C., A stoichiometric complex of neurexins and dystroglycan in brain (2001) J. Cell Biol., 23, pp. 435-445
dc.descriptionSuthagar, E., Soudamani, S., Yuvaraj, S., Ismail Khan, A., Aruldhas, M.M., Balasubramanian, K., Effects of streptozotocin (STZ)-induced diabetes and insulin replacement on rat ventral prostate (2008) Biomed. Pharmacother, , Epub ahead of print)
dc.descriptionTesone, M., Valle, L.B.S., Foglia, V.G., Charreau, E.H., Endocrine function of the testis in streptozotocin diabetic rats (1976) Acta Physiol. Lat., 26, pp. 387-394
dc.descriptionTesone, M., Oliveira-Filho, R.M., Valle, L.B., Androgen receptors in the diabetic rat (1980) Diabetologia, 18, pp. 385-390
dc.descriptionTuxhorn, J.A., Ayala, G.E., Rowley, D.R., Reactive stroma in prostate cancer progression (2001) J. Urol., 166, pp. 2472-2483
dc.descriptionUntergasser, G., Madersbacher, S., Berger, P., Benign prostatic hyperplasia: Age-related tissue-remodeling (2005) Exp. Gerontol., 40, pp. 121-128
dc.descriptionWang, Z.J., Ikeda, K., Foster, H.E., Weiss, R.M., Latifpour, J., Expression and localization of basic fibroblast growth factor in diabetic rat prostate (2000) BJU Int., 85, pp. 945-952
dc.descriptionWeir, M.L., Oppizzi, M.L., Henry, M.D., Dystroglycan loss disrupts polarity and beta-casein induction in mammary epithelial cells by perturbing laminin anchoring (2006) J. Cell Sci., 119, pp. 4047-4058
dc.descriptionWill, J.C., Vinicor, F., Calle, E.E., Is diabetes mellitus associated with prostate incidence and survival? (1999) Epidemiology, 10, pp. 313-318
dc.descriptionWinder, S.J., The complexities of dystroglycan (2001) TIBS, 26, pp. 118-124
dc.descriptionWong, Y.C., Xie, W., Tsao, S.W., Structural changes and alteration in expression of TGF-beta1 and its receptors in prostatic intraepithelial neoplasia (PIN) in the ventral prostate of noble rats (2000) Prostate, 45, pp. 289-298
dc.descriptionYamano, S., Atkinson, J.C., Baum, B.J., Fox, P.C., Salivary gland cytokine expression in NOD and normal BALB/c mice (1999) Clin. Immunol., 92, pp. 265-275
dc.descriptionZar, J.H., (1999) Biostatistical Analysis., , New Jersey: Prentice Hall, pp. 663
dc.languageen
dc.publisher
dc.relationInternational Journal of Experimental Pathology
dc.rightsfechado
dc.sourceScopus
dc.titleDystroglycan Patterns On The Prostate Of Non-obese Diabetic Mice Submitted To Glycaemic Control
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución